The Efficacy of a 6-point Transscleral Suture Fixation of a 3-looped Haptics PC-IOL Implantation Through Scleral Pockets for Surgical Management for Microspherophakia

NCT ID: NCT04447157

Last Updated: 2020-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-01

Study Completion Date

2020-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

By comparing the preoperative data and postoperative data of 9 patients of microspherophakia, we concluded that the 6-point transscleral suture fixation of a 3-looped haptics posterior chamber intraocular lens (PC-IOL) through scleral pockets was a feasible method of PC-IOL implantation in the surgical treatment of microspherophakia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microspherophakia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Microspherophakia

This is a non-interventional study(NIS). All the patients diagnosed as microspherophakia are included in the study and recieved intraocular lens implantation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Microspherophakia was diagnosed and lens diameter\<9mm;
* The lens subluxation was beyond the range of one quadrant and glasses cannot correct the vision;
* Lens dislocated into the anterior chamber;
* Lens dislocation caused elevated intraocular pressure (IOP);
* The lens contacted the corneal endothelium;
* Cataract;
* Corneal endothelial cell density\>1000/mm2;
* The fundus was normal without retinal detachment, severe macular disease and optic nerve atrophy;
* There was possible improvement in postoperative visual acuity measured by retinometer.

Exclusion Criteria

* The lens is centered and the position of the lens is stable;
* Glasses can correct the vision obviously;
* The reason for the elevated IOP was independent with the lens;
* A high possibility of corneal decompensation after surgery;
* Fundus function was poor and it is not expected to improve the vision after surgery;
* Combined with other ocular diseases which were not suitable for IOL implantation;
* Combined with a systemic disease that the patient cannot tolerate the surgery.
Minimum Eligible Age

10 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

xuwen2020-465

Identifier Type: -

Identifier Source: org_study_id